Search for: "ENDO PHARMACEUTICAL HOLDINGS, INC."
Results 41 - 60
of 61
Sort by Relevance
|
Sort by Date
23 Oct 2011, 5:08 pm
J&J’s Gynecare TVT later became a predicate for the IVS Tunneller I, made by Dublin-based Covidien, and the Sparc Sling, made by the American Medical Systems unit of Endo Pharmaceuticals Holdings Inc. [read post]
30 Sep 2011, 8:05 am
Fellow mesh makers, including Johnson & Johnson (NYSE:JNJ) and Endo Pharmaceuticals Holdings Inc. [read post]
8 Sep 2011, 9:51 pm
Manufacturers including J&J and Endo Pharmaceuticals Holdings Inc. [read post]
8 Sep 2011, 9:55 am
If accepted by the FDA, manufacturers, such as Johnson & Johnson, Endo Pharmaceuticals Holdings, Inc. and C.R. [read post]
24 Aug 2011, 12:33 am
The lobbying push for a PTE (FDA Law Blog) US: Generics fees: A fantastic opportunity (profitability through simplicity) USPTO announces agenda for next BCP customer partnership meeting (Patent Docs) US: GOP candidates unified in opposition to embryonic cell research (Patent Docs) US: District Court Massachusetts: Method of detecting fetal down syndrome passes muster under Bilski‘s machine-or-transformation test: PerkinElmer, Inc., et. al. v. [read post]
14 Jul 2011, 8:40 pm
(now part of Pennsylvania-based Endo Pharmaceuticals) and Coloplast. [read post]
4 May 2011, 7:52 am
Author Tron Emptage, who holds a BS in Pharmacy, is Chief Clinical & Compliance Officer with Progressive Medical. [read post]
25 Apr 2011, 3:24 am
(PFE), Johnson & Johnson (JNJ) and Endo Pharmaceuticals Holdings Inc. [read post]
25 Apr 2011, 3:19 am
(PFE), Johnson & Johnson (JNJ) and Endo Pharmaceuticals Holdings Inc. [read post]
8 Dec 2010, 6:07 pm
Other GnRH drugs include Watson Pharmaceuticals Inc's Trelstar and Endo Pharmaceuticals Holdings Inc's Vantas. [read post]
12 Oct 2010, 8:56 pm
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
1 Dec 2009, 9:45 am
Born Free Holdings Ltd. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US:… [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
9 Jan 2009, 8:21 pm
By Jason Derry --Endo to Acquire Indevus On January 5, 2009, Endo Pharmaceuticals Holdings Inc. announced that it will buy Indevus Pharmaceuticals Inc. for an initial payment of about $370 million and an additional $267 million, based on certain milestones. [read post]
29 Aug 2008, 1:25 pm
: (IP finance), Facebook removes international access to Scrabulous, except from India: (Ars Technica), (Techdirt), Reverse engineering can resolve conflict between standardisation and competition: (Techdirt), Benefits of piracy aren’t always in the expected places: (Techdirt) Events 1-3 September: Federation of Indian Chambers of Commerce and Industry, Department of Industrial Property and Promotion, and WIPO conference on ‘Development and IP: Building synergies… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
10 Jul 2008, 5:31 pm
Nov. 6, 2000 & July 9, 2001).Texas: Ethicon Endo-Surgery, Inc. v. [read post]
1 Feb 2008, 12:00 am
: (IPBiz),State of the Union address 28 Jan 2008: statement regarding patenting human life: (IPBiz), (Patently-O),Alnylam Pharmaceuticals secures UK patent covering molecules that affect RNA interference: (SmartBrief),Doha style compulsory licences for exports: The politics…: (Spicy IP),Pushing to compulsory licensing: Pharma companies heading closer to Doha: (Spicy IP),Financial Express on the battle between big pharma companies and the… [read post]
6 Jul 2007, 4:29 am
Hoffman-La Roche, Inc., 618 N. [read post]
